Access cutting-edge glioblastoma treatment through this clinical trial at a research site in Summit. Study-provided care at no cost to qualified participants.
Access glioblastoma specialists in Summit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioblastoma treatment provided free
This clinical trial is testing the safety and efficacy of NanO2TM administered via intravenous infusion in combination with standard radiation and chemotherapy. NanO2TM is being developed to increase the amount of oxygen delivered to tumors which is hoped to increase the effectiveness of radiation therapy.
Sponsor: NuvOx LLC
Check if you qualify for this glioblastoma clinical trial in Summit, NJ
If you're searching for glioblastoma treatment options in Summit, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Summit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.